1. Home
  2. ELS vs NBIX Comparison

ELS vs NBIX Comparison

Compare ELS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELS

Equity Lifestyle Properties Inc.

HOLD

Current Price

$63.87

Market Cap

13.2B

Sector

Real Estate

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$128.58

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELS
NBIX
Founded
1992
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
13.2B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
ELS
NBIX
Price
$63.87
$128.58
Analyst Decision
Buy
Strong Buy
Analyst Count
10
22
Target Price
$70.85
$180.36
AVG Volume (30 Days)
1.2M
906.6K
Earning Date
04-20-2026
05-04-2026
Dividend Yield
3.39%
N/A
EPS Growth
2.55
41.95
EPS
2.01
4.67
Revenue
$1,531,382,000.00
$161,626,000.00
Revenue This Year
$3.97
$22.85
Revenue Next Year
$4.69
$10.36
P/E Ratio
$31.87
$28.21
Revenue Growth
0.34
977.51
52 Week Low
$57.63
$92.32
52 Week High
$69.00
$160.18

Technical Indicators

Market Signals
Indicator
ELS
NBIX
Relative Strength Index (RSI) 44.91 45.23
Support Level $58.56 $124.09
Resistance Level $68.73 $136.74
Average True Range (ATR) 1.00 4.22
MACD 0.10 0.16
Stochastic Oscillator 66.45 40.54

Price Performance

Historical Comparison
ELS
NBIX

About ELS Equity Lifestyle Properties Inc.

Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the US with a higher concentration in the Sunbelt; 38% of the company's properties are in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations. More than 70% of the company's properties are either age-restricted or have an average resident age over 55.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: